Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.
- DOI
- 10.1002/cam4.6184
- Published
- 2023 Jul
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.6184,
title = {Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.},
author = {Iwasaku M and Uchino J and Chibana K and Tanzawa S and Yamada T and Tobino K and Uchida Y and Kijima T and Nakatomi K and Izumi M and Tamiya N and Kimura H and Fujita M and Honda R and Takumi C and Yamada T and Kaneko Y and Kiyomi F and Takayama K},
year = {2023},
journal = {Cancer medicine},
doi = {10.1002/cam4.6184},
url = {https://doi.org/10.1002/cam4.6184}
}RIS
TY - JOUR TI - Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial. AU - Iwasaku M AU - Uchino J AU - Chibana K AU - Tanzawa S AU - Yamada T AU - Tobino K AU - Uchida Y AU - Kijima T AU - Nakatomi K AU - Izumi M AU - Tamiya N AU - Kimura H AU - Fujita M AU - Honda R AU - Takumi C AU - Yamada T AU - Kaneko Y AU - Kiyomi F AU - Takayama K PY - 2023 JO - Cancer medicine DO - 10.1002/cam4.6184 UR - https://doi.org/10.1002/cam4.6184 ER -
APA
M, I., J, U., K, C., S, T., T, Y., K, T., Y, U., T, K., K, N., M, I., N, T., H, K., M, F., R, H., C, T., T, Y., Y, K., F, K., & K, T. (2023). Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.. Cancer medicine. https://doi.org/10.1002/cam4.6184
Source records
- pubmed · retrieved 2026-09-27T12:14:36.381Z